Hadassah to Conduct Clinical Trial of Israeli-Made COVID-19 Vaccine
The Hadassah Medical Organization is slated to begin a clinical trial with an Israeli-made COVID-19 vaccine in October. One hundred volunteers are being recruited to
MYOR Begins US Commercialization of its Breakthrough Platform to Prevent Allergic Conditions
MYOR‘s NURTURE Precision Infant Care enables prevention of food allergies and atopic dermatitis via early prediction in newborns. NURTURE, a clinical decision support tool, provides
Enlivex’s Experimental Allocetra Drug Saves Five Covid Patients at Hadassah Hospital
Hadassah Hospital released five fully recuperated patients who were in critical condition with coronavirus, due to their treatment with the experimental drug, Allocetra developed by
Novellus Raises $57M!
Novellus, Ltd., a Jerusalem-based clinical-stage biotechnology company focused on precision oncology and cancer treatment, raised $ 57 million in a Series C financing round in
BiondVax Pharmaceuticals Universal Flu Vaccine Pivotal Phase 3 Study Results by End October
BiondVax Pharmaceuticals Ltd. (Nasdaq: BVXV) ’s pivotal Phase 3 trial in Europe was completed in June 2020 and the analysis of the results are expected
WizeCare Smart Physical Therapy Homecare Co to Raise $1M via Crowd Funding
You can participate in the WizeCare crowdfunding campaign https://pipelbiz.com/Campaign/52785. Concerns about health and safety in the face of the coronavirus pandemic have seen many clinics
Visibly Impaired Read More Efficiently than the Sighted via OrCam’s Breakthrough!
Jerusalem-based OrCam Technologies announced the US release of a new, voice-activated, interactive Smart Reading feature providing users who are blind, visually impaired, or have reading
BrainsWay Receives FDA Clearance for Ending Smoking Addiction in Adults
BrainsWay Ltd. (NASDAQ & TASE: BWAY), a global leader in the advanced non-invasive treatment of brain disorders, has received 510(k) clearance from the U.S. Food
Concenter BioPharma Successfully Uses Crowdfunding to Finance Its Pill To End Diabetes!
Concenter BioPharma has raised $407 K (as of August 24 1.3 Million NIS) in just ten days using the PipelBiZ Crowdfunding Platform! Concenter Biopharma launched
